These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 397210)

  • 1. Adriamycin cardiotoxicity in stage IV breast cancer: possible enhancement with prior left chest radiation therapy.
    Kinsella TJ; Ahmann DL; Giuliani ER; Lie JT
    Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1997-2002. PubMed ID: 397210
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic irradiation and adriamycin cardiotoxicity.
    Bhanot P; Cushing B; Philippart A; Das L; Farooki Z
    J Pediatr; 1979 Oct; 95(4):561-3. PubMed ID: 225461
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer.
    Hardenbergh PH; Recht A; Gollamudi S; Come SE; Hayes DF; Shulman LN; O'Neill A; Gelman RS; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):69-72. PubMed ID: 10477008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.
    Legha SS; Benjamin RS; Mackay B; Ewer M; Wallace S; Valdivieso M; Rasmussen SL; Blumenschein GR; Freireich EJ
    Ann Intern Med; 1982 Feb; 96(2):133-9. PubMed ID: 7059060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute cardiogenic postoperative edema after doxorubicin (adriamycin) chemotherapy].
    Boulay G; Debaene B
    Ann Fr Anesth Reanim; 1998; 17(1):43-6. PubMed ID: 9750682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
    Harris L; Batist G; Belt R; Rovira D; Navari R; Azarnia N; Welles L; Winer E;
    Cancer; 2002 Jan; 94(1):25-36. PubMed ID: 11815957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug counters doxorubicin cardiotoxicity; not for use at start of chemotherapy.
    Am J Health Syst Pharm; 1995 Oct; 52(19):2076. PubMed ID: 8535936
    [No Abstract]   [Full Text] [Related]  

  • 9. Adriamycin and radiation: synegistic cardiotoxicity.
    Merrill J; Greco FA; Zimbler H; Brereton HD; Lamberg JD; Pomeroy TC
    Ann Intern Med; 1975 Jan; 82(1):122-3. PubMed ID: 1235752
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed cardiac effects of adjuvant doxorubicin and radiotherapy in breast cancer patients].
    Sack H
    Strahlenther Onkol; 1999 Jun; 175(6):293-4. PubMed ID: 10392172
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the cardiotoxic effects of antineoplastic antibiotics adriamycin and pharmorubicin].
    Valvere VIu; Shkhvatsabaia LV; Niu-Tian-de GB
    Kardiologiia; 1989 Sep; 29(9):64-7. PubMed ID: 2687558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
    Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors.
    Prout MN; Richards MJ; Chung KJ; Joo P; Davis HL
    Cancer; 1977 Jan; 39(1):62-5. PubMed ID: 188540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
    Shapiro CL; Hardenbergh PH; Gelman R; Blanks D; Hauptman P; Recht A; Hayes DF; Harris J; Henderson IC
    J Clin Oncol; 1998 Nov; 16(11):3493-501. PubMed ID: 9817266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin cardiomyopathy--risk factors.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer; 1977 Apr; 39(4):1397-402. PubMed ID: 856438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 20. Adriamycin cardiotoxicity in man.
    Rinehart JJ; Lewis RP; Balcerzak SP
    Ann Intern Med; 1974 Oct; 81(4):475-8. PubMed ID: 4277990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.